BioMarin Pharmaceutical Inc. buy Piper Sandler
Start price
23.02.24
/
50%
€84.34
Target price
23.02.25
€98.83
Performance (%)
-22.62%
End price
24.02.25
€65.26
Summary
This prediction ended on 24.02.25 with a price of €65.26. The price of BioMarin Pharmaceutical Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -22.62%. Piper_Sandler has a follow-up prediction for BioMarin Pharmaceutical Inc. where he still thinks BioMarin Pharmaceutical Inc. is a Buy. Piper_Sandler has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| BioMarin Pharmaceutical Inc. | -1.003% | -1.003% | -28.278% |
| iShares Core DAX® | 0.734% | -0.964% | 17.910% |
| iShares Nasdaq 100 | -2.686% | -2.409% | 4.267% |
| iShares Nikkei 225® | -2.261% | -4.038% | 10.420% |
| iShares S&P 500 | -1.346% | -1.510% | 1.615% |
Comments by Piper_Sandler for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) had its price target lowered by analysts at Piper Sandler from $115.00 to $107.00. They now have an "overweight" rating on the stock.
Ratings data for BMRN provided by MarketBeat
In the thread Trading BioMarin Pharmaceutical Inc.
Die von Piper_Sandler gewählte maximale Laufzeit wurde überschritten
Current prediction by Piper_Sandler for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€68.34
20.02.25
20.02.25
€120.57
20.02.26
20.02.26
-33.57%
12.12.25
12.12.25
Stopped prediction by Piper_Sandler for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€75.46
05.09.24
05.09.24
€109.96
05.09.25
05.09.25
-34.85%
06.09.25
06.09.25
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€80.88
27.08.24
27.08.24
€95.81
27.08.25
27.08.25
-38.16%
28.08.25
28.08.25